Ronald R. Blanck, Director at TENAX THERAPEUTICS, INC. (TENX), bought 5,000 shares at $0.95 ($5K) on 2020-05-18, disclosed to the SEC on 2020-05-19.
Open-market purchase of $5k TENX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| TENX | BUY | 2015-11-19 | $6K | — | Filing → |
| TENX | BUY | 2015-11-19 | $15K | — | Filing → |
| TENX | BUY | 2015-01-20 | $7K | — | Filing → |